Hematologic neoplasm (disorder)
Causes of Clonal Blood Cell Disorders study
Year Started: 2007
Blood and related products, including viable cells and nucleic acids from patients with haematological disorders with clonal origins, such as leukaemia, myeloproliferative disorders, myelodysplasia, myeloma, lymphoma and related conditions. Samples collected at diagnosis or before commencing therapy where possible; and at progression of disease if available, in patients of all ages and gender. Samples collected as part of the REC-approved Causes of Clonal Blood Cell Disorders study.
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | 0 - 3 months |
Clinical records | 0 - 3 months |
Followup records | 0 - 3 months |
Freezer temperature logs | 0 - 3 months |
Genomic datasets | 0 - 3 months |
Pathology records | 0 - 3 months |
Quality indicators | 0 - 3 months |
Treatment records | 0 - 3 months |
Unknown
Data not recorded
3001 - 5000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen liquid phase | N/A | Affected | 75% -99% |
Unknown
Data not recorded
3001 - 5000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
DNA | -60°C to -85°C | N/A | Affected | 100% |
Unknown
Data not recorded
3001 - 5000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
RNA | -60°C to -85°C | N/A | Affected | 75% -99% |
Unknown
Data not recorded
3001 - 5000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Serum | -60°C to -85°C | N/A | Affected | 51 - 75% |
Unknown
Data not recorded
3001 - 5000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Plasma | -60°C to -85°C | N/A | Affected | 26 - 50% |
Leukemia, disease (disorder)
UK MPN sample bank
Year Started: 2007
UK MPN sample bank contains samples from over 3000 patients with myeloproliferative neoplasms with associated clinical and research genomic data where available. The collection incorporates the PT1 trial sample cohort.
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
Biomarker datasets | 0 - 3 months |
Clinical records | 0 - 3 months |
Followup records | 0 - 3 months |
Genomic datasets | 0 - 3 months |
Treatment records | 0 - 3 months |
Unknown
Data not recorded
3001 - 5000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen liquid phase | N/A | Affected | 51 - 75% |
Unknown
Data not recorded
3001 - 5000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
DNA | -60°C to -85°C | N/A | Affected | 75% -99% |
Unknown
Data not recorded
3001 - 5000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Serum | -60°C to -85°C | N/A | Affected | 75% -99% |
Unknown
Data not recorded
3001 - 5000 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
RNA | -60°C to -85°C | N/A | Affected | 75% -99% |